Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study - Quiz - MDSpire

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

  • By

  • Ugo Falagario

  • Ivan Jambor

  • Pekka Taimen

  • Kari T. Syvänen

  • Esa Kähkönen

  • Harri Merisaari

  • Ileana Montoya Perez

  • Juha Knaapila

  • Aida Steiner

  • Janne Verho

  • Ashutosh Tewari

  • Hannu J. Aronen

  • Giuseppe Carrieri

  • Peter J. Boström

  • Otto Ettala

  • August 10, 2020

  • 0 min

Share

Original Source(s)

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

  • by Ugo Falagario, Ivan Jambor, Pekka Taimen, Kari T. Syvänen, Esa Kähkönen, Harri Merisaari, Ileana Montoya Perez, Juha Knaapila, Aida Steiner, Janne Verho, Ashutosh Tewari, Hannu J. Aronen, Giuseppe Carrieri, Peter J. Boström, Otto Ettala

  • August 10, 2020

Related Content

Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors

Illumination matters Part III: Impact of light obstruction on illuminance from flexible ureteroscopes — a comparative PEARLS analysis

99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer